Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Assess which option is safer for your needs—software or hardware wallets—by weighing security risks, accessibility, and practical safeguards.
21,982 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Archer Aviation teams with defense innovator Anduril to roll out a new autonomous VTOL platform, blending commercial ...
Stratasys beat on both earnings and revenue, yet stratasys stock just crashed as investors weighed guidance and marke...
Fresh demand signals and disciplined supply dynamics are setting up Micron stock for potential upside. This guide bre...
A high-profile venture capital tie-up is stirring markets as a rising firm expands rapidly. Reports say Donald Trump ...
If SpaceX goes public, the market could shift toward a new era of space commerce. This guide breaks down the three cr...
Tech sell-off drags crypto lower as Bitcoin moves in step with slumping tech shares; analysts warn of continued volat...
Morgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
Online buzz can influence money choices. This guide explains how analysis claims thousands bots may distort engagemen...
A federal case tied a Florida billing company to $64 million in Medicare brace claims linked to a Rock Island nursing...
Aptos has seen a notable price drop even with multiple upbeat developments. This deep dive explains what’s driving th...
Cardano’s Van Rossem hard fork is set to activate tomorrow, amid a surge in whale buying and rising open interest. Tr...